Global Prurigo Nodularis Treatment And Management Market By Type (Corticosteroids, Injectable, Topical, Oral, Emollients, Capsacin Cream, Antihistamines, And Others), By Application (Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies), By Region And Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends And Forecast 2019–2028

Published date: Sep 2021
Report ID: 26849
Number of Pages: 252
Format:

- 1. Prurigo Nodularis Treatment and Management Market Introduction
  - 1.1. Definition
  - 1.2. Taxonomy
  - 1.3. Research Scope
- 2. Executive Summary
  - 2.1. Key Findings by Major Segments
  - 2.2. Top strategies by Major Players
- 3. Global Prurigo Nodularis Treatment and Management Market Overview
  - 3.1. Prurigo Nodularis Treatment and Management Market Dynamics
    3.1.1. Drivers
    3.1.2. Opportunities
    3.1.3. Restraints
    3.1.4. Challenges
  - 3.2. PESTLE Analysis
  - 3.3. Opportunity Map Analysis
  - 3.4. PORTER'S Five Forces Analysis
  - 3.5. Market Competition Scenario Analysis
  - 3.6. Product Life Cycle Analysis
  - 3.7. Opportunity Orbits
  - 3.8. Manufacturer Intensity Map
- 4. Global Prurigo Nodularis Treatment and Management Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
  - 4.1. Global Prurigo Nodularis Treatment and Management Market Analysis by Type: Introduction
  - 4.2. Market Size and Forecast by Region
  - 4.3. Corticosteroids
  - 4.4. Injectable
  - 4.5. Topical
  - 4.6. Oral
  - 4.7. Emollients
  - 4.8. Capsacin Cream
  - 4.9. Antihistamines
  - 4.10. Others
- 5. Global Prurigo Nodularis Treatment and Management Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
  - 5.1. Global Prurigo Nodularis Treatment and Management Market Analysis by Application: Introduction
  - 5.2. Market Size and Forecast by Region
  - 5.3. Hospital Pharmacies
  - 5.4. Retail Pharmacies
  - 5.5. Online Pharmacies
- 6. Global Prurigo Nodularis Treatment and Management Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
  - 6.1. North America
    6.1.1. North America Prurigo Nodularis Treatment and Management Market: Regional Trend Analysis
    6.1.1.1. US
    6.1.1.2. Canada
    6.1.1.3. Mexico
  - 6.2.1. Europe
    6.2.1. Europe Prurigo Nodularis Treatment and Management Market: Regional Trend Analysis
    6.2.1.1. Germany
    6.2.1.2. France
    6.2.1.3. UK
    6.2.1.4. Russia
    6.2.1.5. Italy
    6.2.1.6. Rest of Europe
  - 6.3. Asia-Pacific
    6.3.1. Asia-Pacific Prurigo Nodularis Treatment and Management Market: Regional Trend Analysis
    6.3.1.1. China
    6.3.1.2. Japan
    6.3.1.3. Korea
    6.3.1.4. India
    6.3.1.5. Rest of Asia
  - 6.4. Latin America
    6.4.1. Latin America Prurigo Nodularis Treatment and Management Market: Regional Trend Analysis
    6.4.1.1. Brazil
    6.4.1.2. Argentina
    6.4.1.3. Rest of Latin America
  - 6.5. Middle East and Africa
    6.5.1. Middle East and Africa Prurigo Nodularis Treatment and Management Market: Regional Trend Analysis
    6.5.1.1. GCC
    6.5.1.2. South Africa
    6.5.1.3. Israel
    6.5.1.4. Rest of MEA
- 7. Global Prurigo Nodularis Treatment and Management Market Competitive Landscape, Market Share Analysis, and Company Profiles
  - 7.1. Market Share Analysis
  - 7.2. Company Profiles
  - 7.3. Bayer AG
    7.3.1. Company Overview
    7.3.2. Financial Highlights
    7.3.3. Product Portfolio
    7.3.4. SWOT Analysis
    7.3.5. Key Strategies and Developments
  - 7.4. Pfizer Inc.
    7.4.1. Company Overview
    7.4.2. Financial Highlights
    7.4.3. Product Portfolio
    7.4.4. SWOT Analysis
    7.4.5. Key Strategies and Developments
  - 7.5. GlaxoSmithKline plc.
    7.5.1. Company Overview
    7.5.2. Financial Highlights
    7.5.3. Product Portfolio
    7.5.4. SWOT Analysis
    7.5.5. Key Strategies and Developments
  - 7.6. Teva Pharmaceutical Industries Ltd
    7.6.1. Company Overview
    7.6.2. Financial Highlights
    7.6.3. Product Portfolio
    7.6.4. SWOT Analysis
    7.6.5. Key Strategies and Developments
  - 7.7. Johnson & Johnson Services Inc.
    7.7.1. Company Overview
    7.7.2. Financial Highlights
    7.7.3. Product Portfolio
    7.7.4. SWOT Analysis
    7.7.5. Key Strategies and Developments
  - 7.8. Merck & Co. Inc.
    7.8.1. Company Overview
    7.8.2. Financial Highlights
    7.8.3. Product Portfolio
    7.8.4. SWOT Analysis
    7.8.5. Key Strategies and Developments
  - 7.9. Sanofi SA
    7.9.1. Company Overview
    7.9.2. Financial Highlights
    7.9.3. Product Portfolio
    7.9.4. SWOT Analysis
    7.9.5. Key Strategies and Developments
  - 7.10. Takeda Pharmaceutical Company Limited
    7.10.1. Company Overview
    7.10.2. Financial Highlights
    7.10.3. Product Portfolio
    7.10.4. SWOT Analysis
    7.10.5. Key Strategies and Developments
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
- Bayer AG Company Profile
- Pfizer Inc Company Profile
- GlaxoSmithKline plc.
- Teva Pharmaceutical Industries Ltd. Company Profile
- Johnson & Johnson Services Inc.
- Merck & Co. Inc.
- Sanofi SA
- Takeda Pharmaceutical Company Limited
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $5,999 $2,999 USD / per unit save 50%	Multi User $7,999 $3,499 USD / per unit save 55%	Corporate User $12,999 $4,499 USD / per unit save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 2,999)	Buy Now ($ 3,499)	Buy Now ($ 4,499)